Yep. The possibilities are either (a) ineptitude/overpromising/inability to meet a deadline or (b) the scoping study is so unfavourable that it's better to delay and try to improve it than to release, even at the cost of shredding credibility. Both terrible options.
Yep. The possibilities are either (a)...
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add E25 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.005(2.04%) |
Mkt cap ! $52.20M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 24.5¢ | 24.0¢ | $15.34K | 62.79K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 41909 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 13600 | 1 |
View Market Depth
| Last trade - 15.32pm 21/06/2024 (20 minute delay) ? |
| E25 (ASX) Chart |